Objective This study aims to explore the efficacy of tetrahydrocurcumin (THC), the major active metabolite of curcumin, on high glucose (HG)-induced human platelet aggregation and activation as well as to clarify the underlying mechanisms in vitro. Methods Purified platelets prepared from healthy subjects were pre-incubated with various concentrations of THC (0.5 μmol/L, 1 μmol/L or 10 μmol/L) or vehicle control (0.05% DMSO) for 40 min at 37°C, followed by the stimulation of normal glucose (NG, 5 mmol/L) or HG (25 mmol/L) for additional 90 min. The maximal aggregation rate was determined by an aggregometer. Flow cytometry was used to measure platelet surface expression of CD62P (a typical marker of platelet activation) and generation of total intraplatelet reactive oxygen species (ROS). Meanwhile, the phosphorylation level of platelet p53 was detected by Western blot assay. Results Compared with NG group, HG intervention significantly increased platelet aggregation (P < 0.05) and CD62P expression (P < 0.001), which were greatly inhibited by different concentrations of THC (P < 0.05). Mechanistically, when compared with solvent control, THC significantly decreased the level of total ROS production (P < 0.001) and p53 phosphorylation (P < 0.05). In addition, HG-induced total intraplatelet ROS generation (P < 0.001) and p53 phosphorylation (P < 0.05) were greatly attenuated by adding a ROS scavenger N-acetyl-L-cysteine (NAC). The combination of NAC with THC (10 μmol/L) showed no additive inhibitory effects (P > 0.05). Moreover, platelet aggregation and activation induced by HG were greatly decreased by NAC and a p53 specific inhibitor PFT-μ (P < 0.05). The combination of THC (10 μmol/L) and NAC resulted no additive inhibitory effects on HG-increased platelet aggregation and activation (P > 0.05). THC (10 μmol/L) exhibited additive inhibitory effects on platelet aggregation (P < 0.05) but no additive inhibitory effects on platelet activation when combined with PFT-μ (P > 0.05). Conclusions THC exerts a protective effect on HG-induced platelet aggregation and activation possibly through down-regulating ROS/p53 signaling pathway in human platelets in vitro. The current study may provide potential value for THC to improve thrombosis in diabetes mellitus and the related chronic metabolic diseases.